期刊
MOLECULAR ENDOCRINOLOGY
卷 23, 期 10, 页码 1525-1531出版社
ENDOCRINE SOC
DOI: 10.1210/me.2009-0069
关键词
-
资金
- Deutsche Forschungsgemeinschaft
Glucocorticoids (GCs) are efficient drugs that are used to treat various immune-mediated diseases, but their long-term administration is associated with multiple metabolic side effects, including osteoporosis. Molecular analyses of the mechanisms exerted by the GC receptor have resulted in the development of GC receptor agonists that selectively repress or activate GC target genes. This review summarizes the cellular and molecular effects of GCs on bone cells and highlights the critical signaling pathways that may evolve into future therapeutic strategies. ( Molecular Endocrinology 23: 1525-1531, 2009)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据